Corbus Pharmaceuticals
CRBP
CRBP
103 hedge funds and large institutions have $224M invested in Corbus Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 28 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.45% more ownership
Funds ownership: 1.22% → 1.67% (+0.45%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
41% less call options, than puts
Call options by funds: $2.38M | Put options by funds: $4.03M
Holders
103
Holding in Top 10
1
Calls
$2.38M
Puts
$4.03M
Top Buyers
| 1 | +$48.6M | |
| 2 | +$7.45M | |
| 3 | +$5.04M | |
| 4 |
BlackRock
New York
|
+$1.76M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.53M |
Top Sellers
| 1 | -$1.74M | |
| 2 | -$1.55M | |
| 3 | -$917K | |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$626K |
| 5 |
Goldman Sachs
New York
|
-$463K |